We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novavax Expects Late-Stage U.S./Mexico COVID-19 Vaccine Trial to Start Within Weeks
Novavax Expects Late-Stage U.S./Mexico COVID-19 Vaccine Trial to Start Within Weeks
Novavax said it will begin a delayed phase 3 trial in the U.S. and Mexico to evaluate its COVID-19 vaccine candidate, NVX-CoV2373, “in the coming weeks” and that its 15,000-person late-stage trial in the UK is now fully enrolled.